E.g., 06/28/2022
E.g., 06/28/2022
Title Category Credit Event date Price
Curso en vivo de avances globales en cáncer de próstata: el rol de las pruebas genéticas y los inhibidores de PARP (2022) - Espanol
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
06/15/2022 $0.00 Curso Virtual CME de Cortesía!Miércoles, 15 de junio de 2022 a las 07:00 p.m. EDTAvances globales en cáncer de próstata: El Rol de las pruebas genéticas y los inhibidores de PARP es una nueva e interesante iniciativa global educativa que presenta una serie de cuatro cursos virtuales interactivos, basados en casos, ofrecidos en inglés, mandarín, portugués y español.
Curso en vivo de avances globales en cáncer de próstata: mejores prácticas en terapia hormonal (2022) - Espanol
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
06/29/2022 $0.00 Curso Virtual CME de Cortesía!El 29 de Junio de 2022 I 7:00 - 8:00 p.m. EDTAvances globales en cáncer de próstata: mejores prácticas en terapia hormonal (2022) es una nueva y emocionante iniciativa educativa global en la que un moderador y otros dos expertos en la materia participarán en una presentación y debate interactivo con el estilo de una entrevista.
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Kidney cancer is not a single disease; it is made up of several different types of cancer, each with a different histology, a different clinical course, responding differently to therapy and caused by different genes. After completing this course, attendees be able to describe the different types of kidney cancer and the genes that cause each. They will learn how to identify the different types of inherited versus sporadic forms of kidney cancer.
Diversity Equity and Inclusion in Urology: What Do We Need to Know Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The course will review the statistics of underrepresented minorities in urology and why Diversity, Equity and Inclusion (DEI) initiatives are necessary for the advancement of urology. We will define racism and educate participants on the different forms of racism. We will identify current tactics to increase the number of underrepresented minorities in urology.
Educational Assessments $0.00 What is an assessment?  Why do we need them? 
Engaging Disparities in Prostate Cancer Care Webcast (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00
Establishing Your Independent Urologic Research Lab (2022) $39.00 NEW COMPLIMENTARY COURSEFOR AUA MEMBERS! 
Evolving Landscape of Androgen Deprivation Therapy in Advanced Prostate Cancer Podcast (2021)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA has developed a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Fundamentals in Urology (2022) 07/08/2022 $820.00
Fundamentals in Urology Webcast (2021) $655.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms.
Genetic Testing in Prostate Cancer: Clinical Implications for Early Detection and Management of Localized and Advanced Disease Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 There has been a dramatic increase in our understanding of the role of genetic testing in prostate cancer over the last several years. While the clinical impact of the breast cancer gene (BRCA1/2) mutations has been well established in the setting of breast and ovarian cancer with critical implications for treatment (e.g.
Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease, & Castration Resistant Prostate...
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 There has been a dramatic increase in our understanding of the role of genetic testing in prostate cancer over the last several years. While the clinical impact of BRCA1/2 mutations has been well established in the setting of breast and ovarian cancer with critical implications for treatment (e.g.
Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors (2022) - English
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
04/13/2022 $0.00 Complimentary CME Virtual Course!Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors is an exciting new global educational initiative featuring a series of four interactive, case-based, live virtual courses conducted in English, Man
How Can We Improve SDM From a Prostate Cancer Survivor's Perspective Podcast (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Engaging Disparities in Prostate Cancer Care consists of multiple educational activities featuring a variety of formats for the urologic healthcare team to reinforce the essentials of SDM to better assist high-risk patients in regards to prostate cancer screening and treatment. A live webinar, Clinical Problem Solving (CPS) Protocol, and Podcast Series will enable participants to be better prepared to apply SDM in their practice and comply with the recently proposed USPSTF Grade C recommendation for PSA screening.
How to Safely and Properly Administer Immunotherapies Podcast (2021)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA has developed a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.

Pages